Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK

Shah A., Prieto-Alhambra D., Hawley S., Delmestri A., Lippett J., Cooper C., Judge A., Javaid MK.

Objective: Describe UK regional variation in prescription of anti-osteoporosis drug therapy before and after a primary hip fracture during 1999–2013.

More information

DOI

10.1007/s00198-016-3743-z

Type

Conference paper

Publisher

Springer Verlag

Publication Date

22/09/2016

Volume

27